Child Neurology Society
Look for us at CNS 2026!
Nationwide Children’s faculty actively support the Child Neurology Society (CNS), the preeminent professional association of child neurologists in the United States, Canada and worldwide. We are proud to have a large team of clinicians contributing to, presenting or leading programs at this year’s meeting, October 14-17 in Montréal, Québec. Come see us in the exhibit hall to meet our faculty and learn about our programs and training opportunities.
Exhibit Hours:
- Wednesday (10/14): 2 to 7:30 p.m. (Welcome Reception starts at 6 p.m.)
- Thursday (10/15): 11:30 a.m. to 7 p.m. (Wine & Cheese Reception starts at 5 p.m.)
View Nationwide Children's Faculty Involvement View 2026 Poster Presentation Schedule
Visit the Child Neurology Society for more information.
Nationwide Children's Faculty Involvement
Shawn C. Aylward, MD, will lead special interest group (SIG) sessions on Friday, October 16 — the Headache SIG and the Cerebral Spinal Fluid Pressure Disorders SIG.
Warren D. Lo, MD, will present “Seizure Status Modifies Response to Motor Rehabilitation in Perinatal Arterial Ischemic Stroke; the I-ACQUIRE Trial” during Platform Session 2 on Friday, October 16. The presentation is designated PL2-6.
John R. Mytinger, MD, will present “A Prognostic Biomarker for Refractory Epilepsy After Infantile Epileptic Spasms Syndrome - Validation of the 2021 BASED Score” during Platform Session 2 on Friday, October 16. The presentation is designated PL2-5. Dr. Mytinger serves on the CNS International Affairs Committee.
Adam P. Ostendorf, MD, will serve as faculty for the John M. “Jack” Pellock Resident Seminar on Epilepsy, held in conjunction with the CNS Annual Meeting.
Anup D. Patel, MD, will participate in Workshop 3, “Child Neurology QI Lab: Practical Tools & Real-World Examples.”
Margie A. Ream, MD, PhD, will serve on the faculty for the CNS Genetics Summit on Tuesday, October 13. On Wednesday, October 14, she will chair the Child Neurology/NDD Educators Symposium, “The Evolving Landscape of Residency Training,” where she will present the “Welcome and Match Update” and co-lead a roundtable discussion on “Residency Application Review and Recruitment Best Practices.” Nationwide Children’s child neurology resident Jackson Mittlesteadt, DO, will participate in the symposium’s roundtable discussion on osteopathic education.
Jorge A. Vidaurre, MD, will present “Rare Diseases and Genomics Beyond Borders: Are We Leaving Parts of the World Behind?” during the CNS Genetics Summit on Tuesday, October 13. He will also review notable 2026 literature on diversity, equity and inclusion and social determinants of health during Symposium III: “Year in Review” on Saturday, October 17. Dr. Vidaurre serves as board liaison on the CNS International Affairs and Professional Development committees.
Poster Presentations
Nationwide Children’s staff will present the following research during Exhibits and Poster Review.
Emily C. De Los Reyes, MD, will present two posters: #413, “Improved Developmental Outcomes With Early Initiation of Cerliponase Alfa Treatment in Children With CLN2 Disease,” and #416, “Cerliponase Alfa for the Treatment of CLN2 Disease: Combined Results From Two Ongoing Observational Studies.
Maxim Dragoun, MD, will present poster #376, “Anti-NMDAR Encephalitis Following La Crosse Infection: A Novel Presentation.
Amy M. Garee, PCPNP, will present poster #410, “Implementing a Standardized, Hospital-Wide Initiative to Protect Designated Intracerebroventricular (ICV) Reservoirs for Cerliponase Alfa, or Brineura, Infusions From Unintended Use.
Jennifer L. McKinney, MD, will present poster #415, “Conduction Block in Early Infantile Krabbe Disease.
Jackson Mittlesteadt, DO, will present poster #273, “A Domain-Based Severity Scoring System and Natural History Analysis of TBCD Neurodegenerative Disorder.